Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pugan Tablets (扑感片) is a traditional Chinese medicine (TCM) combination product developed and manufactured by Jiangxi Wannianqing Pharmaceutical. It is specifically formulated for the treatment of wind-cold type common cold and influenza. The medication typically combines herbal ingredients known for their diaphoretic and antitussive properties with Western pharmaceutical agents such as paracetamol (an analgesic and antipyretic) and chlorpheniramine maleate (an antihistamine). It is administered orally in tablet form to relieve symptoms such as fever, headache, nasal congestion, and sore throat associated with viral respiratory infections. The product is approved and marketed in China for these indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pugan Tablets.